Eli Lilly and Company Sustainability Profile
Eli Lilly and Company, commonly referred to as Lilly, is a global leader in the pharmaceutical industry, headquartered in the United Kingdom. Founded in 1876, the company has established a strong presence in major operational regions, including North America, Europe, and Asia, focusing on innovative solutions in diabetes, oncology, immunology, and neuroscience. Lilly is renowned for its pioneering products, such as insulin therapies and cancer treatments, which are distinguished by their commitment to research and development. The company has achieved significant milestones, including the introduction of groundbreaking medications that have transformed patient care. With a robust market position, Eli Lilly continues to be recognised for its contributions to healthcare, consistently ranking among the top pharmaceutical companies worldwide.
DitchCarbon Score
How does Eli Lilly and Company's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Pharmaceutical Preparation Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
Eli Lilly and Company's score of 68 is higher than 79% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Let us know if this data was useful to you
Eli Lilly and Company's reported carbon emissions
In 2024, Eli Lilly and Company reported total greenhouse gas emissions of approximately 192,000,000 kg CO2e for Scope 1 and about 258,000,000 kg CO2e for Scope 2 (market-based). This brings their combined Scope 1 and 2 emissions to around 450,000,000 kg CO2e. In 2023, the company recorded Scope 1 emissions of about 182,000,000 kg CO2e and Scope 2 emissions of approximately 345,000,000 kg CO2e (market-based), with total Scope 1 and 2 emissions reaching about 527,000,000 kg CO2e. Notably, Eli Lilly's Scope 3 emissions were significant, amounting to approximately 5,139,500,000 kg CO2e in 2023. Eli Lilly has set ambitious climate commitments, aiming for a 26% absolute reduction in emissions from 2020 to 2023 across their operations. They achieved this target, reporting a 26% reduction in emissions by 2023, despite business growth. Furthermore, the company is committed to achieving carbon neutrality in its operations (Scope 1 and 2 emissions) by 2030, with plans to enhance reporting on full value-chain emissions. The company has demonstrated a proactive approach to sustainability, with a focus on reducing greenhouse gas emissions while maintaining operational growth. Eli Lilly's efforts reflect a commitment to addressing climate change and contributing to a more sustainable future.
Unlock detailed emissions data
Access structured emissions data, company-specific emission factors, and source documents
| 2007 | 2008 | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Scope 1 | 502,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 |
| Scope 2 | 1,310,000,000 | 0,000,000,000 | 0,000,000,000 | 0,000,000,000 | 0,000,000,000 | 000,000,000 | 0,000,000,000 | 0,000,000,000 | 0,000,000,000 | 0,000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 |
| Scope 3 | 200,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | - | 0,000,000,000 | 0,000,000,000 | 0,000,000,000 | - |
How Carbon Intensive is Eli Lilly and Company's Industry?
How Carbon Intensive is Eli Lilly and Company's Location?
Eli Lilly and Company's Climate Goals (2030 & 2050)
Climate goals typically focus on 2030 interim targets and 2050 net-zero commitments, aligned with global frameworks like the Paris Agreement and Science Based Targets initiative (SBTi) to ensure alignment with global climate goals.
Eli Lilly and Company has established climate goals through participation in recognized frameworks and target-setting initiatives. Companies often set interim 2030 targets and long-term 2050 net-zero goals to demonstrate measurable progress toward decarbonization.
